Clinical Trial Update: IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 trial of IV ibuprofen to prevent post-ERCP pancreatitis was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-ercp Acute Pancreatitis

Drugs mentioned

• Ibuprofen (IV) (ibuprofen)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Post-ERCP Acute Pancreatitis | Phase 2 | Status: TERMINATED | Results posted: 2020-02-18